Medical Devices Startups
6,308 companies tagged Medical Devices, with their investors and founders.
Madrigal Pharmaceuticals is a biopharmaceutical company developing treatments for metabolic-associated steatohepatitis (MASH). The company focuses on improving care for patients with this liver disease through innovative drug development and collaboration.
2 investors
Magnet Biomedicine develops TrueGlue™, a molecular glue discovery platform for designing small molecule therapeutics that induce novel protein-protein interactions to treat cancer and immune disorders. The platform systematically identifies molecular glues capable of targeting historically difficult-to-drug proteins in precision medicine.
2 investors
Marani develops maternity care technology to improve access to prenatal and obstetric care for expectant mothers and providers. The platform delivers pregnancy-specific insights to reduce maternal and infant health disparities in the United States.
2 investors
Mars Dental develops AI-powered guidance software for dental implant surgery, enabling general dentists to perform implant placement procedures with greater accuracy and confidence. The company targets US dentists seeking to expand their surgical capabilities.
2 investors
Maxwell Biomedical develops a device-based alternative to catheter ablation for atrial fibrillation, using closed-loop adaptive left atrial multisite pacing and Spatial Resynchronization Therapy (SRT) to terminate AF without high-energy shock. Its work centers on wirelessly powered leadless pacemakers and cardiac resynchronization technology for cardiac rhythm disorders.
2 investors
MB2 Dental is a dental partnership organization (DPO) that partners with general dentists and specialists, providing shared services, capital access, and practice management support while letting dentists retain ownership and autonomy. It operates across the United States, serving dental practice owners.
2 investors
MDalgorithms develops AI-powered personalized skincare and hair care solutions, including treatments for acne, hair regrowth, and anti-aging. The company uses machine learning models and proprietary image analysis technology to deliver customized treatment kits tailored to each user's specific skin and hair profile.
2 investors
mDETECT develops methylation- and NGS-based liquid biopsy tests to monitor metastatic cancer, aimed at clinical validation and commercial diagnostic use. The company's work centers on tracking disease in patients battling metastatic cancer.
2 investors
MDxHealth is a commercial-stage precision diagnostics company offering molecular diagnostic tests to guide the diagnosis and treatment of prostate cancer and other urologic diseases. Its tests use proprietary genetic, epigenetic, and molecular technologies and serve physicians, patients, payers, and providers.
2 investors
Mezoo develops an ambulatory remote patient monitoring (aRPM) solution built around its HiCardi system, a wearable medical device that measures ECG data to diagnose arrhythmia in patients from newborns to adults. The device is used by medical professionals and is adopted by major hospitals in Korea, with expansion into global healthcare markets.
2 investors
MedaSystems builds a software platform that automates workflows, collects real-world data, and connects physicians with pharmaceutical manufacturers to manage drugs under pre-approval and expanded-access pathways. It serves pharmaceutical companies and academic institutions in the United States and Europe.
2 investors
Medasense develops a noninvasive sensor platform and AI technology for objective pain measurement, helping clinicians personalize pain management and avoid overmedication. Its products serve hospitals and clinicians in the pain management and medical device market.
2 investors
MedCheck aggregates real-world clinical data from healthcare professionals in emerging markets through a cloud-based platform to enable data-driven decision-making. The company connects physicians, medical organizations, NGOs, and pharmaceutical firms to improve healthcare outcomes via electronic medical records, clinical study portals, and data analytics tools.
2 investors
Medipixel develops AI-based clinical solutions in the medical technology field, working with hospitals and healthcare partners. The company combines medical technology with clinical expertise to support diagnosis and treatment.
2 investors
Medium Bio engineers customized proteins using AI and protein design to create affinity reagents for research teams and diagnostic developers. The company accelerates molecular tool development from design to experimental validation within weeks.
2 investors
BD Medical manufactures Arctic Sun, a non-invasive temperature control system for targeted temperature management in critically ill patients across neonatal, pediatric, and adult care settings. The solution includes hardware, software, analytics, training, and proprietary hydrogel pads designed to improve clinical outcomes in critical care.
2 investors
MedPharm is a contract development and manufacturing organization (CDMO) focused on topical, transdermal, and transepithelial drug products, supporting formulation development, in vitro testing, and GMP manufacturing from early development through commercial supply. It serves pharmaceutical and biotechnology companies, with facilities in Guildford, UK, and Durham, North Carolina, USA.
2 investors
Meduloc develops minimally invasive intramedullary implants for internal fixation of small and long-bone fractures. Its products are intended for orthopedic surgeons treating fracture patients in the medical device field.
2 investors
Medyria addresses the diagnosis of angina pectoris, focusing on coronary conditions such as Coronary Artery Disease (CAD) and Non-Obstructive Coronary Artery Disease (NOCAD) linked to coronary microvascular dysfunction. The company positions itself around cardiovascular diagnostics where standard tests fail to identify NOCAD and CMD patients in time.
2 investors
Medytox is a South Korean biopharmaceutical company that develops and manufactures botulinum toxin products and hyaluronic acid dermal fillers. Founded in 2000, it operates domestic R&D centers and production plants in Korea along with subsidiaries and joint ventures in the US, Taiwan, Hong Kong, Thailand, and Japan.
2 investors
Mellitus Health develops FDA-cleared decision-support software that helps clinicians optimize insulin dosing for diabetes patients by analyzing glucometer readings and providing patient-specific dosage adjustments. The platform is designed for primary care providers managing insulin therapy in clinical settings.
2 investors
Momentis develops the Anovo Surgical System, a robotic surgery platform that supports a transvaginal, minimally-invasive approach with high articulation and reach. The system is aimed at surgeons and hospitals seeking to reduce cost and improve operating room efficiency.
2 investors
Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature. The medical device company runs clinical studies in deep vein thrombosis and below-the-knee peripheral arterial disease, with applications in cardiovascular treatment and denervation for hypertension.
2 investors
Merit Medical Systems designs, develops, manufactures and markets medical devices for interventional and diagnostic procedures. The company serves healthcare providers and clinical practitioners in the medical device industry.
2 investors